Maryland State Retirement & Pension System Seagen Inc. Transaction History

Maryland State Retirement & Pension System

$4.65 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$187.64 - $206.25 $9,757 - $10,725	-52 Reduced 0.48%	10,700 $2.06 Million
Q1 2023 Apr 20, 2023	BUY	$127.59 - $203.08 $36,618 - $58,283	287 Added 2.74%	10,752 $2.18 Million
Q4 2022 Jan 17, 2023	BUY	$117.37 - $139.17 $1.23 Million - $1.46 Million	10,465 New	10,465 $0
Q2 2022 Aug 01, 2022	BUY	$108.81 - $179.33 $38,953 - $64,200	358 Added 3.54%	10,465 $1.85 Million
Q2 2021 Jul 13, 2021	BUY	$135.08 - $161.1 $54,977 - $65,567	407 Added 4.2%	10,107 $1.54 Million
Q1 2021 May 10, 2021	BUY	$137.51 - $190.8 $1.05 Million - $1.46 Million	7,648 Added 372.71%	9,700 $1.35 Million
Q4 2020 Feb 04, 2021	BUY	$164.63 - $211.93 $337,820 - $434,880	2,052 New	2,052 $332,000

Others Institutions Holding SGEN

# of Institutions

Shares Held

1.26M

Call Options Held

23K

Put Options Held

55.2K

View Full List

About Seagen Inc.

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

More about SGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.

Account